Press releases & Statements

26/04/2023

Vaccines Europe response to the publication of the proposal for the revised General Pharmaceutical Legislation

Read Article

09/11/2022

New guidance to improve inconsistencies in access and availability of vaccines across Europe 

Read Article

05/09/2022

Pharmaceutical companies to give evidence on responses to Covid-19

Read Article

25/07/2022

Vaccines Europe Statement on Czech Presidency of the Council of the European Union 

Read Article

21/02/2022

COVIDRIVE, a public-private partnership for COVID-19 vaccine effectiveness monitoring in Europe, welcomes three new vaccine companies

Read Article

01/12/2021

Vaccines Europe Statement on Vaccine-Preventable Cancers

Read Article

29/11/2021

EFPIA – Vaccines Europe statement on Omicron variant

Read Article

26/11/2021

The European Commission and Innovative Biopharmaceutical Industries to Explore Potential Initiatives to Enhance Local Production of Vaccines and Treatments in Africa

Read Article

17/11/2021

EFPIA and Vaccines Europe position on the European Health Emergency preparedness and Response Authority (HERA)

Read Article

21/09/2021

Launch of an ambitious cross-pharma study by the public-private partnership ‘COVIDRIVE’: a multi-country European study to continuously monitor COVID-19 vaccine effectiveness against severe disease

Read Article

16/09/2021

HERA: Putting Europe on the front foot against global health threats

Read Article

16/09/2021

EFPIA-Vaccines Europe Statement on State of the Union Address

Read Article